Literature DB >> 9564697

Vitrectomy for diabetic retinopathy in patients undergoing hemodialysis for associated end-stage renal failure.

H Hayashi1, Y Kurata, Y Imanaga, K Goya, K Oshima.   

Abstract

PURPOSE: Candidates for diabetic vitrectomy often have concurrent renal dysfunction and have undergone hemodialysis. The influence of hemodialysis on the surgical outcome of vitrectomy was investigated.
METHODS: Vitrectomy was performed on 76 eyes with proliferative diabetic retinopathy in 66 patients with end-stage renal failure who had undergone hemodialysis. Follow-up was longer than 1 year.
RESULTS: No uncontrollable hemorrhage occurred either during or immediately after the surgery. Final visual acuity after surgery was the same as preoperative visual acuity in 31.5% of the eyes; improvement was seen in 60.5% of the eyes. A final visual acuity of 0.2 or better was observed in 57.6% of the eyes. Major postoperative complications included recurrent vitreous hemorrhage, rhegmatogenous retinal detachment, fibrin clot formation, neovascular glaucoma, flat anterior chamber, and a transient rise in intraocular pressure.
CONCLUSION: Renal failure and hemodialysis do not appear to have a deteriorative influence on the outcome of vitrectomy for proliferative diabetic retinopathy. A flat anterior chamber seems to be a rare and perhaps unique postoperative complication of gas-filled eyes in patients who have undergone hemodialysis.

Entities:  

Mesh:

Year:  1998        PMID: 9564697     DOI: 10.1097/00006982-199818020-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Ocular findings, surgery details and outcomes in proliferative diabetic retinopathy patients with chronic kidney disease.

Authors:  Jipeng Li; Aman Chandra; Lin Liu; Lin Zhang; Jun Xu; Meng Zhao
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

2.  Use and safety of heparin-free maintenance hemodialysis in the USA.

Authors:  Jenny I Shen; Aya A Mitani; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2013-04-05       Impact factor: 5.992

3.  Surgical outcomes of vitrectomy surgery for proliferative diabetic retinopathy in patients with abnormal renal function.

Authors:  P Larrañaga-Fragoso; H Laviers; C McKechnie; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-22       Impact factor: 3.117

Review 4.  Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.

Authors:  Jenny I Shen; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2012-05-05       Impact factor: 8.860

5.  Hemodialysis with end-stage renal disease did not raise the risk of intracranial hemorrhage after a head injury.

Authors:  Hsin-Hung Chen; Chien-Chin Hsu; Shih-Feng Weng; Hung-Jung Lin; Jhi-Joung Wang; How-Ran Guo; Shih-Bin Su; Chien-Cheng Huang; Jiann-Hwa Chen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-10-28       Impact factor: 2.953

6.  A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal.

Authors:  Long Su; Guannan Huang; Songtao Yin; Xia Hua; Xin Tang
Journal:  BMC Ophthalmol       Date:  2018-02-08       Impact factor: 2.209

7.  Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis.

Authors:  Yusuke Kameda; Ko Hanai; Yasuko Uchigata; Tetsuya Babazono; Shigehiko Kitano
Journal:  J Diabetes Investig       Date:  2019-11-09       Impact factor: 4.232

8.  Relationship between renal function and prognosis of Chinese proliferative diabetic retinopathy patients undergoing the first vitrectomy: protocol for a prospective cohort study.

Authors:  Chunyan Lei; Keren Zhang; Tiancong Chang; Qibo Ran; Meixia Zhang
Journal:  BMJ Open       Date:  2021-12-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.